Correlation Between Tscan Therapeutics and ISPIM

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tscan Therapeutics and ISPIM at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tscan Therapeutics and ISPIM into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tscan Therapeutics and ISPIM 77, you can compare the effects of market volatilities on Tscan Therapeutics and ISPIM and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tscan Therapeutics with a short position of ISPIM. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tscan Therapeutics and ISPIM.

Diversification Opportunities for Tscan Therapeutics and ISPIM

-0.08
  Correlation Coefficient

Good diversification

The 3 months correlation between Tscan and ISPIM is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and ISPIM 77 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ISPIM 77 and Tscan Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tscan Therapeutics are associated (or correlated) with ISPIM. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ISPIM 77 has no effect on the direction of Tscan Therapeutics i.e., Tscan Therapeutics and ISPIM go up and down completely randomly.

Pair Corralation between Tscan Therapeutics and ISPIM

Given the investment horizon of 90 days Tscan Therapeutics is expected to under-perform the ISPIM. In addition to that, Tscan Therapeutics is 14.42 times more volatile than ISPIM 77. It trades about -0.01 of its total potential returns per unit of risk. ISPIM 77 is currently generating about -0.04 per unit of volatility. If you would invest  9,998  in ISPIM 77 on September 2, 2024 and sell it today you would lose (27.00) from holding ISPIM 77 or give up 0.27% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Tscan Therapeutics  vs.  ISPIM 77

 Performance 
       Timeline  
Tscan Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tscan Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
ISPIM 77 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ISPIM 77 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, ISPIM is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Tscan Therapeutics and ISPIM Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tscan Therapeutics and ISPIM

The main advantage of trading using opposite Tscan Therapeutics and ISPIM positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tscan Therapeutics position performs unexpectedly, ISPIM can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ISPIM will offset losses from the drop in ISPIM's long position.
The idea behind Tscan Therapeutics and ISPIM 77 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Fundamental Analysis
View fundamental data based on most recent published financial statements